Literature DB >> 20100838

Promyelocytic leukemia protein controls cell migration in response to hydrogen peroxide and insulin-like growth factor-1.

Erin L Reineke1, Yu Liu, Hung-Ying Kao.   

Abstract

Promyelocytic leukemia protein (PML) was originally identified as part of a chromosomal translocation that contributes to the development of acute promyelocytic leukemia (APL). Since its discovery, PML has been found to play diverse roles in different cellular processes. Notably, PML has anti-proliferative and pro-apoptotic activity that supports its role as a tumor suppressor. We have previously shown that the peptidyl-prolyl isomerase Pin1 is able to affect cell proliferation and hydrogen peroxide (H(2)O(2))-mediated cell death through modulation of the steady-state levels of PML. We have extended these studies to show that the interaction between PML and Pin1 is targeted by multiple extracellular signals in the cell. We show that H(2)O(2) up-regulates and IGF-1 down-regulates PML expression in a Pin1-dependent manner. Interestingly, we found that H(2)O(2)- and IGF-1-mediated alteration in PML accumulation regulate MDA-MB-231 cell migration. Furthermore, we show that the control of cell migration by PML, and thus H(2)O(2) and IGF-1, results from PML-dependent decreased expression of integrin beta1 (ITGB1). Knockdown of Pin1 leads to decreased cell migration, lower levels of ITGB1 expression and resistance to IGF-1- and H(2)O(2)-induced changes in cell migration and ITGB1 expression. Taken together, our work identifies PML as a common target for H(2)O(2) and IGF-1 and supports a novel tumor suppressive role for PML in controlling cell migration through the expression of ITGB1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20100838      PMCID: PMC2843199          DOI: 10.1074/jbc.M109.063362

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  PML protein isoforms and the RBCC/TRIM motif.

Authors:  K Jensen; C Shiels; P S Freemont
Journal:  Oncogene       Date:  2001-10-29       Impact factor: 9.867

2.  BCR/ABL expression of myeloid progenitors increases beta1-integrin mediated adhesion to stromal cells.

Authors:  Fernando A Fierro; Anna Taubenberger; Pierre-Henri Puech; Gerhard Ehninger; Martin Bornhauser; Daniel J Muller; Thomas Illmer
Journal:  J Mol Biol       Date:  2008-02-05       Impact factor: 5.469

3.  Role of SUMO-1-modified PML in nuclear body formation.

Authors:  S Zhong; S Müller; S Ronchetti; P S Freemont; A Dejean; P P Pandolfi
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

Review 4.  Review: properties and assembly mechanisms of ND10, PML bodies, or PODs.

Authors:  G G Maul; D Negorev; P Bell; A M Ishov
Journal:  J Struct Biol       Date:  2000-04       Impact factor: 2.867

5.  Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.

Authors:  M Bartucci; C Morelli; L Mauro; S Andò; E Surmacz
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

6.  Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells.

Authors:  Erin L Reineke; Minh Lam; Qing Liu; Yu Liu; Kristopher J Stanya; Kun-Sang Chang; Anthony R Means; Hung-Ying Kao
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

Review 7.  Regulation of apoptosis by PML and the PML-NBs.

Authors:  R Bernardi; A Papa; P P Pandolfi
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

8.  Ski regulates muscle terminal differentiation by transcriptional activation of Myog in a complex with Six1 and Eya3.

Authors:  Hong Zhang; Ed Stavnezer
Journal:  J Biol Chem       Date:  2008-11-12       Impact factor: 5.157

9.  Role of promyelocytic leukemia (PML) protein in tumor suppression.

Authors:  E M Rego; Z G Wang; D Peruzzi; L Z He; C Cordon-Cardo; P P Pandolfi
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

10.  Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.

Authors:  V Lallemand-Breitenbach; J Zhu; F Puvion; M Koken; N Honoré; A Doubeikovsky; E Duprez; P P Pandolfi; E Puvion; P Freemont; H de Thé
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

View more
  21 in total

1.  Mitogen-activated protein kinase extracellular signal-regulated kinase 2 phosphorylates and promotes Pin1 protein-dependent promyelocytic leukemia protein turnover.

Authors:  Jun Hee Lim; Yu Liu; Erin Reineke; Hung-Ying Kao
Journal:  J Biol Chem       Date:  2011-10-27       Impact factor: 5.157

2.  Ubiquitination of tumor suppressor PML regulates prometastatic and immunosuppressive tumor microenvironment.

Authors:  Ya-Ting Wang; Jocelyn Chen; Chou-Wei Chang; Jayu Jen; Tzu-Yu Huang; Chun-Ming Chen; Roger Shen; Suh-Yuen Liang; I-Cheng Cheng; Shuenn-Chen Yang; Wu-Wei Lai; Kuang-Hung Cheng; Tao-Shih Hsieh; Ming-Zong Lai; Hung-Chi Cheng; Yi-Ching Wang; Ruey-Hwa Chen
Journal:  J Clin Invest       Date:  2017-07-10       Impact factor: 14.808

Review 3.  Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins.

Authors:  Yih-Cherng Liou; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Trends Biochem Sci       Date:  2011-08-17       Impact factor: 13.807

4.  KLHL39 suppresses colon cancer metastasis by blocking KLHL20-mediated PML and DAPK ubiquitination.

Authors:  H Y Chen; J Y Hu; T H Chen; Y C Lin; X Liu; M Y Lin; Y D Lang; Y Yen; R H Chen
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

5.  PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.

Authors:  Hong-Yi Kuo; Yen-Sung Huang; Chin-Hsiu Tseng; Yi-Chen Chen; Yu-Wei Chang; Hsiu-Ming Shih; Cheng-Wen Wu
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

6.  The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein.

Authors:  D Guan; D Factor; Yu Liu; Z Wang; H-Y Kao
Journal:  Oncogene       Date:  2012-09-03       Impact factor: 9.867

7.  Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα).

Authors:  Xiwen Cheng; Yu Liu; Hao Chu; Hung-Ying Kao
Journal:  J Biol Chem       Date:  2012-05-15       Impact factor: 5.157

8.  MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironment.

Authors:  Yu-Ting Su; Madison Butler; Meili Zhang; Wei Zhang; Hua Song; Lee Hwang; Andy D Tran; Ryan E Bash; Allison N Schorzman; Ying Pang; Guangyang Yu; William C Zamboni; Xiaodong Wang; Stephen V Frye; Christopher Ryan Miller; Dragan Maric; Masaki Terabe; Mark R Gilbert; Henry Shelton Earp Iii; Jing Wu
Journal:  Neurooncol Adv       Date:  2020-06-03

Review 9.  The role of PML ubiquitination in human malignancies.

Authors:  Ruey-Hwa Chen; Yu-Ru Lee; Wei-Chien Yuan
Journal:  J Biomed Sci       Date:  2012-08-30       Impact factor: 8.410

10.  New Strategies to Direct Therapeutic Targeting of PML to Treat Cancers.

Authors:  Kamil Wolyniec; Dennis A Carney; Sue Haupt; Ygal Haupt
Journal:  Front Oncol       Date:  2013-05-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.